Clinical Trials Directory

Trials / Completed

CompletedNCT06290518

Modulation of Reproductive Microbiota by Ligilactobacillus Salivarius CECT5713

Modulation of the Reproductive Microbiota as a Strategy to Increase Rates of Reproductive Success in Couples With Infertility of Unknown Origin

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Biosearch S.A. · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of the project is to elucidate if the oral administration of Ligilactobacillus salivarius CECT5713 is capable of improving the rates of term pregnancies in couples with infertility problems of unknown cause. On the other hand, the project is aimed to detect microbiological, immunological and hormonal markers that allow the identification of couples in which the administration of the strain could be particularly effective. This is a randomized, double-blind, parallel-group controlled nutritional intervention study. The intervention (Ligilactobacillus salivarius CECT5713 or placebo) will be performed during the 6 months prior to the fertility treatment and during the first IVF cycle (estimated 1-2 months). In case of pregnancy, the woman will continue the treatment until 12 weeks of gestation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLigilactobacillus salivarius CECT5713Oral administration of a capsule containing 9.5 log10 cfu of the strain.
DIETARY_SUPPLEMENTPlaceboOral administration of a capsule containing maltodextrin.

Timeline

Start date
2020-09-01
Primary completion
2023-05-03
Completion
2024-01-29
First posted
2024-03-04
Last updated
2024-03-04

Locations

3 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT06290518. Inclusion in this directory is not an endorsement.